Anzeige
Mehr »
Montag, 23.02.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Verteidigung: Drohnen-Player vor nächstem Bewertungssprung?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
164 Leser
Artikel bewerten:
(1)

Olympian Gabby Thomas, BetterWay Blood Testing to Host 'Track Like Gabby' Happy Hour During SXSW

The happy hour includes a panel discussion with three-time Olympic gold medalist Gabby Thomas, Web Golinkin, President of Babson Diagnostics, and Fred Turner, co-founder and CEO of Curative, and interactive games with Gabby Thomas

AUSTIN, TX / ACCESS Newswire / February 23, 2026 / BetterWay blood testing by Babson Diagnostics, a science-first healthcare technology company transforming diagnostic blood testing, today announced it will host "Track Like Gabby x BetterWay: Sprint Toward Better Patient Care Happy Hour" on Friday, March 13, 2026, from 6:00-8:00 p.m. at The Capital Factory (located in the Omni Hotel at 701 Brazos Street, Austin, TX) in the ACL Room (16th floor).

Designed for healthcare innovators, leaders and investors, the happy hour will spotlight how an elevated patient experience in blood testing can fuel ambulatory care growth, strengthen adherence, and improve patient engagement. Olympic sprinter and public health advocate Gabby Thomas will share insights from the Track Like Gabby powered by BetterWay campaign-an initiative focused on helping people take a more proactive, data-driven role in their health through routine blood testing and consistent tracking.

Babson Diagnostics President Web Golinkin will lead a panel discussion with Gabby Thomas and Fred Turner, co-founder and CEO of Curative. The conversation will explore how healthcare leaders and partners:

  • Measure and improve patient outcomes compared to benchmark data

  • Use patient experience as a lever for ambulatory growth and adherence

  • Emphasize the value of baseline testing and stronger patient-provider conversations

  • Leverage Track Like Gabby to help people feel ownership and motivation in managing their health

In addition, Gabby Thomas will host an interactive games activation where attendees can compare their flexibility, reaction time and grip strength to an Olympic athlete and participate in discussions with Gabby on how she leverages baseline testing in her own health.

All attendees for this event must also register for CF House, which can be done for free here.

Attendees can experience the patient-friendly BetterWay fingertip collection on Friday, March 13th from 9 am - 5 pm at the Innovation Expo on the ground floor of the Capital Factory (located in the Omni Hotel). Complimentary BetterWay Hemoglobin A1c and Lipid Panels will be available with a $4 clinician oversight fee, allowing attendees to seamlessly integrate health screenings into their festival experience. They will receive easy-to-understand test results in one to two days.

Attendees can pre-book appointments by texting "TRACK" to BetterWay Customer Support at (512) 877-8770 or simply walk up at the Capital Factory.

"This is an important conversation because the future of healthcare depends on making preventive care something people actually do, not just something we talk about. The panel with Gabby and Fred will explore how patient experience, affordability, and access can work together to improve outcomes and reduce costs," said Web Golinkin, President of Babson Diagnostics.

For more information about this event or the Track Like Gabby initiative, please visit tracklikegabby.com.

About BetterWay Blood Testing by Babson Diagnostics

BetterWay is blood testing reimagined-patient-friendly fingertip collection with accurate lab results. One in three people skip blood testing due to anxiety, fear of needles, difficult venous access, or inconvenience. BetterWay enables blood testing without phlebotomy. This improves patient experience, increases adherence to testing, optimizes staffing efficiency, and advances health equity. BetterWay was developed by Babson Diagnostics, a science-first healthcare technology company that has become the global thought leader in the use of capillary blood for routine testing. Babson was named 2024 Medtech Company of the Year by MD + DI, 2025 SXSW Innovation Award winner for Health & Biotech, and one of Fast Company's 2025 Most Innovative Companies in Healthcare. For more information, please visit BetterWay.com or connect with us on Instagram or LinkedIn.

About Curative

Curative is creating the future of health insurance with its first-of-a-kind employer-based plan, boasting an impressive AM Best rating of A-. Our mission is to transform health insurance by eliminating financial barriers to care and guiding our members at every step of their health journey. With a competitive monthly premium and zero additional costs*, Curative provides employers and their employees exceptional value, improved health, and peace of mind. For more information on Curative, visit https://curative.com or follow us on Facebook, Instagram, X, or LinkedIn.

* Every Curative member qualifies for the $0 deductible, $0 copay for in-network care and preferred prescriptions by completing a Baseline Visit within 120 days of the plan effective date.

SOURCE: BetterWay Blood Testing



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/olympian-gabby-thomas-betterwaytm-blood-testing-to-host-track-like-ga-1139949

© 2026 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.